MRSN
Mersana Therapeutics Inc
Halal Rating :
Last Price
$0.62
Last updated:
Market Cap
-
7D Change
-1.03%
1 Year Change
-78.19%
Company Overview
Industries
Exchange
Next Earnings Date
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for the treatment of various cancers. The company leverages its proprietary platforms to develop targeted therapies with enhanced anti-tumor activity and controlled off-target effects.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $12.6m | $25.65m | - | $986000.0 | 0.00% | 3.84% |
| June 30, 2024 | $2.29m | $28.73m | - | $983000.0 | 0.00% | 3.42% |
| March 31, 2024 | $9.24m | $31.25m | - | $1.0m | 0.00% | 3.21% |
Company Impact
Help us evaluate Mersana Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.